AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇲
Trastuzumab Emtansine in Zambia
2 products registered with ZAMRA — 2 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| Kadcyla Solution for injection in vial | ZAMRA-HM-26-48 | Roche Products | active | 5 Mar 2031 |
| kadcyla Solution For Infusion | ZAMRA-HM-26-18 | Roche Products | active | 14 Jan 2031 |
Trastuzumab Emtansine — ZAMRA Registration Details
ZAMRA (Zambia) has 2 registered products containing Trastuzumab Emtansine, of which 2 are currently active. Data is sourced directly from the official ZAMRA drug register and refreshed daily.
Track Trastuzumab Emtansine registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.